Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash & Equivalents (2016 - 2025)

Cross Country Healthcare's Cash & Equivalents history spans 16 years, with the latest figure at $108.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 33.2% year-over-year to $108.7 million; the TTM value through Dec 2025 reached $108.7 million, up 33.2%, while the annual FY2025 figure was $108.7 million, 33.2% up from the prior year.
  • Cash & Equivalents reached $108.7 million in Q4 2025 per CCRN's latest filing, up from $99.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $108.7 million in Q4 2025 to a low of $279000.0 in Q2 2022.
  • Average Cash & Equivalents over 5 years is $34.6 million, with a median of $15.7 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: tumbled 98.46% in 2022, then soared 10241.9% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $1.0 million in 2021, then skyrocketed by 247.88% to $3.6 million in 2022, then skyrocketed by 374.31% to $17.1 million in 2023, then surged by 377.55% to $81.6 million in 2024, then soared by 33.2% to $108.7 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Cash & Equivalents are $108.7 million (Q4 2025), $99.1 million (Q3 2025), and $81.2 million (Q2 2025).